GKB Ophthalmics Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | (25) | 1.95 | 74.70 | 24.40 |
| Op profit growth | 69.50 | (34) | (205) | (308) |
| EBIT growth | (821) | (92) | (218) | 1,392 |
| Net profit growth | 89.50 | (138) | (35) | 92,888 |
| Profitability ratios (%) | ||||
| OPM | 3.52 | 1.56 | 2.39 | (4) |
| EBIT margin | (1.70) | 0.18 | 2.23 | (3.30) |
| Net profit margin | (3.10) | (1.20) | 3.38 | 9.03 |
| RoCE | (1.50) | 0.24 | 3.12 | (2.80) |
| RoNW | (0.90) | (0.50) | 1.41 | 2.33 |
| RoA | (0.70) | (0.40) | 1.19 | 1.92 |
| Per share ratios () | ||||
| EPS | -- | -- | 6.23 | 9.51 |
| Dividend per share | -- | -- | -- | -- |
| Cash EPS | (11) | (6.40) | 2.78 | 5.93 |
| Book value per share | 118 | 108 | 113 | 108 |
| Valuation ratios | ||||
| P/E | -- | -- | 21.40 | 6.94 |
| P/CEPS | (4) | (18) | 47.90 | 11.10 |
| P/B | 0.37 | 1.07 | 1.18 | 0.61 |
| EV/EBIDTA | 8.72 | 30.30 | 19 | 626 |
| Payout (%) | ||||
| Dividend payout | -- | -- | -- | -- |
| Tax payout | -- | (15) | (87) | 129 |
| Liquidity ratios | ||||
| Debtor days | 164 | 122 | 99.80 | 148 |
| Inventory days | 196 | 147 | 124 | 177 |
| Creditor days | (156) | (114) | (87) | (116) |
| Leverage ratios | ||||
| Interest coverage | 0.67 | (0.10) | (1.30) | 0.88 |
| Net debt / equity | 0.02 | 0.16 | 0.09 | 0.08 |
| Net debt / op. profit | 0.63 | 6.08 | 2.38 | (2) |
| Cost breakup () | ||||
| Material costs | (63) | (67) | (65) | (62) |
| Employee costs | (14) | (12) | (11) | (16) |
| Other costs | (19) | (20) | (21) | (26) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Revenue | 58.50 | 77.90 | 76.40 | 43.80 |
| yoy growth (%) | (25) | 1.95 | 74.70 | 24.40 |
| Raw materials | (37) | (52) | (50) | (27) |
| As % of sales | 63.50 | 67.10 | 65.40 | 62.20 |
| Employee costs | (8.10) | (9) | (8.60) | (6.90) |
| As % of sales | 13.90 | 11.50 | 11.30 | 15.70 |
| Other costs | (11) | (15) | (16) | (11) |
| As % of sales | 19.10 | 19.80 | 20.90 | 26.10 |
| Operating profit | 2.06 | 1.21 | 1.83 | (1.70) |
| OPM | 3.52 | 1.56 | 2.39 | (4) |
| Depreciation | (3.60) | (1.70) | (1.40) | (1.50) |
| Interest expense | (1.50) | (1.30) | (1.30) | (1.60) |
| Other income | 0.57 | 0.62 | 1.30 | 1.79 |
| Profit before tax | (2.50) | (1.10) | 0.41 | (3.10) |
| Taxes | -- | 0.17 | (0.40) | (3.90) |
| Tax rate | -- | (15) | (87) | 129 |
| Minorities and other | -- | -- | -- | -- |
| Adj. profit | (2.50) | (1) | 0.06 | (7) |
| Exceptional items | -- | -- | 2.53 | 11 |
| Net profit | (1.80) | (1) | 2.59 | 3.95 |
| yoy growth (%) | 89.50 | (138) | (35) | 92,888 |
| NPM | (3.10) | (1.20) | 3.38 | 9.03 |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Profit before tax | (2.50) | (1.10) | 0.41 | (3.10) |
| Depreciation | (3.60) | (1.70) | (1.40) | (1.50) |
| Tax paid | -- | 0.17 | (0.40) | (3.90) |
| Working capital | 22.90 | 13.20 | 8.93 | 8.85 |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 16.80 | 10.50 | 7.55 | 0.34 |
| Capital expenditure | 29.70 | 12.50 | 8.46 | 1.58 |
| Free cash flow | 46.50 | 23 | 16 | 1.92 |
| Equity raised | 88.10 | 72.60 | 75.80 | 72.60 |
| Investments | (11) | (12) | (12) | (5.90) |
| Debt financing/disposal | 1.52 | (5.20) | (5.30) | (1.40) |
| Dividends paid | -- | -- | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 125 | 78.40 | 74.90 | 67.20 |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Equity capital | 5.04 | 7.55 | 4.15 | 4.15 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 54.20 | 47.30 | 40.80 | 42.60 |
| Net worth | 59.30 | 54.80 | 44.90 | 46.80 |
| Minority interest | ||||
| Debt | 15.20 | 14.10 | 9.93 | 7.19 |
| Deferred tax liabilities (net) | 2.17 | 2.17 | 1.36 | 1.58 |
| Total liabilities | 76.60 | 71.10 | 56.20 | 55.60 |
| Fixed assets | 26.30 | 25.90 | 18.60 | 18.20 |
| Intangible assets | ||||
| Investments | 1.15 | 0.54 | 0.37 | 3.48 |
| Deferred tax asset (net) | 1.68 | 1.71 | 0.45 | 0.48 |
| Net working capital | 33.60 | 32.90 | 34.30 | 30.60 |
| Inventories | 30.60 | 28.20 | 32 | 30.80 |
| Inventory Days | 191 | -- | 150 | 147 |
| Sundry debtors | 24.90 | 23.50 | 27.50 | 24.70 |
| Debtor days | 156 | -- | 129 | 118 |
| Other current assets | 5.56 | 5.73 | 2.02 | 1.73 |
| Sundry creditors | (24) | (21) | (24) | (24) |
| Creditor days | 149 | -- | 114 | 113 |
| Other current liabilities | (3.70) | (3.20) | (2.90) | (2.90) |
| Cash | 13.90 | 10 | 2.55 | 2.84 |
| Total assets | 76.60 | 71 | 56.20 | 55.60 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Dec-2020 | Dec-2019 | Dec-2018 | - | - |
|---|---|---|---|---|---|
| Gross Sales | 39.60 | 42.40 | 42.20 | -- | -- |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 39.60 | 42.40 | 42.20 | -- | -- |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 0.80 | 0.38 | 0.54 | -- | -- |
| Total Income | 40.40 | 42.80 | 42.70 | -- | -- |
| Total Expenditure ** | 38.80 | 41.20 | 41.90 | -- | -- |
| PBIDT | 1.65 | 1.57 | 0.86 | -- | -- |
| Interest | 1.68 | 0.96 | 1.11 | -- | -- |
| PBDT | -- | 0.62 | (0.20) | -- | -- |
| Depreciation | 2.50 | 2.73 | 2.44 | -- | -- |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- |
| Deferred Tax | -- | -- | (0.10) | -- | -- |
| Reported Profit After Tax | (2.50) | (2.10) | (2.60) | -- | -- |
| Minority Interest After NP | 0.03 | -- | -- | -- | -- |
| Net Profit after Minority Interest | (2) | (1.70) | (2.60) | -- | -- |
| Extra-ordinary Items | -- | -- | -- | -- | -- |
| Adjusted Profit After Extra-ordinary item | (2) | (1.70) | (2.60) | -- | -- |
| EPS (Unit Curr.) | (4) | (3.80) | (5.60) | -- | -- |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 5.04 | 4.64 | 4.64 | -- | -- |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 4.16 | 3.70 | 2.04 | -- | -- |
| PBDTM(%) | (0.10) | 1.46 | (0.60) | -- | -- |
| PATM(%) | (6.40) | (5) | (6.10) | -- | -- |
QuickLinks for GKB Ophthalmics Ltd.
